Access cutting-edge radiation retinopathy treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access radiation retinopathy specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related radiation retinopathy treatment provided free
This randomized controlled trial will evaluate the effect of intravitreal faricimab or fluocinolone acetonide (FAc) intravitreal implant compared with observation on long-term visual acuity following treatment of choroidal melanoma with iodine-125 plaque brachytherapy.
Sponsor: Jaeb Center for Health Research
Check if you qualify for this radiation retinopathy clinical trial in Chicago, IL
If you're searching for radiation retinopathy treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced radiation retinopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.